What does MDM2 do to p53?
The MDM2 protein is a negative regulator of p53. After binding to p53, it inhibits its transcriptional activity, favours its nuclear export and stimulates its degradation. The overexpression of MDM2 in various tumours inhibits p53, therefore favouring uncontrolled cell proliferation.
Does MDM2 ubiquitination p53?
Mdm2 is a key repressor of p53. It is an E3 ligase that promotes p53 ubiquitination and proteasomal degradation. In addition, binding of Mdm2 to p53 can directly inhibit the transcriptional activity of p53 through a number of mechanisms. Mdm2 is ubiquitinated and is degraded by the proteasome.
Is p53 a transcription factor of MDM2?
The Mdm2 gene is transcriptionally activated by p53 through its direct binding to the p53-responsive elements located within the P2 promoter (4).
What is a key role of MDM2?
MDM2 is one of the most highly regulated proteins due to its significant role in modulating p53-dependent and -independent functions in various cancers [2]. In humans, the MDM2 gene was first isolated in 3T3DM cells from double minutes which are extrachromosomal amplified DNAs.
How does MDM2 inactivate p53?
Early studies suggested that the MDM2 oncoprotein negatively regulates p53 activity through the induction of p53 protein degradation. MDM2 serves as an E3 ubiquitin ligase of p53; it catalyzes polyubiquitination and subsequently induces proteasome degradation to downregulate p53 protein level.
How does MDM2 regulate stability of p53?
Endogenous levels of Mdm2 are sufficient to regulate p53 stability, and overexpression of Mdm2 can reduce the amount of endogenous p53. Because mdm2 is transcriptionally activated by p53, this degradative pathway may contribute to the maintenance of low p53 concentrations in normal cells.
How is MDM2 removed from p53?
In the natural setting of the stressed cell, phosphorylation has been proposed to be a key mechanism for blocking the Mdm2-p53 interaction. Phosphorylation of serine 15 and serine 20 at the N terminus of p53 during times of particular DNA damage events may assist in blocking this interaction (Prives and Hall, 1999).
What does ubiquitination of p53 do?
The ubiquitination pathway is a highly dynamic and coordinated process that regulates degradation as well as numerous processes of proteins within a cell. These modifications are critical for the function of p53 and control both the degradation of the protein as well as localization and activity.
Is MDM2 a transcription factor?
MDM2 is highly regulated at both mRNA and protein levels in cells. MDM2 is a transcriptional target of p53. p53 binds to p53 consensus DNA binding element in the first intron of MDM2 gene to transcriptionally induce the expression of MDM2, and forms an auto-regulatory negative feedback loop with MDM2 [30–32].
What causes MDM2 overexpression?
MDM2 amplification has been detected in many human malignancies, including lung cancer, colon cancer and other malignancies. MDM2 overexpression is associated with chemotherapeutic resistance in human malignancies.
How do MDM2 inhibitors work?
Both MDM2 and MDMX also inhibit the transcription activity of p73 tumor suppressor by associating with its N-terminus and inhibiting transcription activity (lower panel). The binding of MDM2 enables the binding of ITCH, E3 ubiquitin ligase of p73 and its proteasomal degradation.
What is the role of Mdm2 and MDMX in p53?
MDM2 and MDMX are critical negative regulators of p53 and p73 transcription activity and protein stability. Both MDM2 and MDMX bind to p53 N-terminus and inhibit its transcription activity (upper panel). Besides, MDM2 monoubiqutinates p53, which induces p53 nuclear export and the inability to regulate the expression of the target genes.
How do Mdm2 and MDMX work together?
MDM2 and MDMX, negative regulators of the tumor suppressor p53, can work separately and as a heteromeric complex to restrain p53’s functions. MDM2 also has pro-oncogenic roles in cells, tissues, and animals that are independent of p53.
What is the function of Mdm2 protein?
The MDM2 protein is the p53 E3 ubiquitin ligase that under cellular stress conditions mono- or polyubiquitinates p53. This facilitates p53 nuclear export and inhibition of transcription activity (monoubiquitination) or ubiquitin-dependent proteasomal degradation of p53 (polyubiquitination).
Can stapled peptides target wt-p53 tumors with Mdm2 and MDMX?
Nowadays, stapled peptides, which bind both to MDM2 and MDMX, see the renascence in targeting wt-p53 tumors. The most advanced, ALRN-6924 peptide, α-helical p53 stapled peptidomimetic, is a potent MDM2/MDMX-antagonist tested in Phase I clinical trials for advanced solid tumors and hematological malignancies 15.